Efficacy and safety of apatinib in patients with recurrent or refractory melanoma.

被引:0
|
作者
Wang, Zibing
Yuan, Shumin
Zhang, Xiaojie
Huang, Hao
Gao, Quanli
机构
[1] Zhengzhou Univ, Dept Immunotherapy, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[2] Henan Canc Hosp, Zhengzhou, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e22026
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Influence of KDR Genetic Variation on the Efficacy and Safety of Patients with Chemotherapy Refractory Metastatic CRC Who Received Apatinib Treatment
    Bai, Ming
    Li, Zhi-Guo
    Ba, Yi
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 1041 - 1055
  • [32] Efficacy and safety of apatinib in patients with untreated or chemotherapy-refractory soft tissue sarcoma: a multicenter, phase 2 trial
    Yu, Wenxi
    Zhang, Hongmei
    Chen, Jing
    Zhang, Xing
    Chen, Yong
    Qu, Guofan
    Huang, Gang
    Zhou, Yuhong
    Ye, Ting
    Fan, Zhengfu
    Yao, Yang
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (18)
  • [33] ASSESSMENT OF THE IMMUNOGENICITY OF NIVOLUMAB (NIVO) AND IPILIMUMAB (IPI) IN COMBINATION AND POTENTIAL IMPACT ON SAFETY AND EFFICACY IN PATIENTS WITH ADVANCED MELANOMA.
    Statkevich, P.
    Passey, C.
    Park, J.
    Saeger, S.
    Bello, A.
    Roy, A.
    Agrawal, S.
    Gupta, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S9 - S9
  • [34] Leveraging survivorship care to identify recurrent melanoma.
    Ward, Andrew Joseph
    McLoughlin, James M.
    Lewis, James M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (07)
  • [35] Efficacy and safety of apatinib in advanced sarcoma
    Chen, J.
    Ye, T.
    Zhang, Z.
    Wang, Z.
    Yang, S.
    Yang, K.
    Li, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [36] Safety and efficacy of electrochemotherapy in a series of patients with nonmetastasized primary or recurrent anorectal malignant melanoma
    Farricha, Victor
    Quaglino, Pietro
    Brizio, Matteo
    de Terlizzi, Francesca
    Bartolo, Joana
    Carvalhal, Sara
    Caraco, Corrado
    Di Monta, Gianluca
    MELANOMA RESEARCH, 2021, 31 (01) : 76 - 80
  • [37] Efficacy and Safety of Apatinib Combined with Etoposide in Patients with Recurrent Platinum-resistant Epithelial Ovarian Cancer: A Retrospective Study
    Huang, Qi
    Chu, Chaonan
    Tang, Jie
    Dai, Zhijie
    JOURNAL OF CANCER, 2020, 11 (18): : 5353 - 5358
  • [38] Efficacy and Safety of Apatinib in the Treatment of Chemotherapy-Refractory Metastatic Colorectal Cancer: A Systematic Review
    Khan, Aujala Irfan
    Mashat, Ghadi D.
    Hazique, Mohammad
    Khan, Kokab Irfan
    Ramesh, Prasana
    Kanagalingam, Suthasenthuran
    Ul Haq, F. N. U. Zargham
    Srinivasan, Nishok Victory
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [39] Apatinib as a Single Agent or Combined with Chemotherapy in Recurrent or Refractory Childhood Solid Tumor Patients
    Lu, S.
    Jia, Z.
    Feifei, S.
    Zijun, Z.
    Juan, W.
    Junting, H.
    Yizhuo, Z.
    Xiaofei, S.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S432 - S432
  • [40] Response to apatinib in patients with osteosarcoma: Updated evidence of efficacy and safety.
    Tu, Chongqi
    Yao, Kai
    Zhou, Yong
    Luo, Yi
    Zhang, Wenli
    Duan, Hong
    Min, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)